Autoimmune diseases, immune modulation, inflammation, and self-tolerance
169 articles
48-week trial shows biological drugs don't outperform standard treatment for patient-reported outcomes in early rheumatoid arthritis.
Updated EULAR recommendations provide evidence-based strategies for managing rheumatoid arthritis using synthetic and biologic medications.
Swedish study finds JAK inhibitors raise keratinocyte cancer risk by 39% compared to TNF inhibitors in RA patients.
New research reveals how blood factors trigger muscle weakness in autoimmune disease and identifies potential therapeutic targets.
Breakthrough study shows CAR T-cell therapy normalizes neutrophil function in lupus, offering new hope for autoimmune treatment.
New study reveals specific immune and microbiome signatures that could predict depression in lupus patients with 85% accuracy.
Updated EULAR recommendations provide comprehensive management strategies for this complex autoimmune condition affecting multiple organs.
New research reveals progress in lupus pregnancy care while highlighting persistent medication and outcome disparities.
Researchers developed accurate diagnostic codes to identify arthritis caused by cancer immunotherapy drugs.
Researchers identified specific lupus patient subgroups who respond dramatically better to baricitinib using gene expression analysis.
Swedish study reveals significant improvements in pregnancy safety for women with systemic lupus erythematosus over 20 years.
New research shows how targeted interleukin-2 treatment can restore regulatory T cells and reduce muscle inflammation in autoimmune conditions.
